Weight Loss Drugs

Illustration of bariatric surgery versus semaglutide medications for weight loss (AI-generated, non-realistic illustration). Credit: Ideogram.

Surgical Weight Loss Triumph: New York Study Reveals Bariatric Surgery Outshines Ozempic by 20% More Body Weight Shed in Two Years

In a groundbreaking study, New York University researchers have revealed that bariatric surgery outperforms popular semaglutide medications, such as Ozempic, by achieving nearly five times greater weight loss over two years, igniting a renewed debate on the most effective strategies for combating obesity.

By Vivian Ho – June 20, 2025

Illustration of injectable obesity medications and their impact on weight loss and glycemic control (AI-generated, non-realistic illustration). Credit: Ideogram.

Real-World Shock: Obesity Drugs Fail to Deliver Promised Weight Loss, Threatening Diabetes Prevention Efforts as Patients Abandon Treatment

In a striking revelation, a Cleveland Clinic study has found that popular injectable obesity medications, semaglutide and tirzepatide, yield significantly less weight loss in real-world settings compared to controlled clinical trials, primarily due to high discontinuation rates and lower maintenance dosages.

By Kristen Harris – June 10, 2025

Illustration of the potential side effects of weight loss drugs like Ozempic, highlighting muscle and bone loss risks (AI-generated, non-realistic illustration). Credit: Ideogram.

“Beware the Hidden Dangers”: Weight Loss Drugs Like Ozempic Linked to Alarming Muscle and Bone Wasting, Experts Warn of Irreversible Damage

As the popularity of weight loss drugs like Ozempic surges, medical experts are sounding alarms about their potentially irreversible side effects, urging users to prioritize informed decisions and responsible usage.

By Vivian Ho – June 3, 2025